25-year disease-free survival rate after irradiation for prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 878-883

  Critz, Frank A ^a,b   Benton, James B ^a   Shrake, Philip ^a   Merlin, Mark L ^a  

^a Radiotherapy Clinics of Georgia   (United States)

^b Radiotherapy Clinics of Georgia   (United States)

Author keywords

brachytherapy; local; neoplasm recurrence; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN; RADIOACTIVE SEED;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84873710922     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.10.061     Document Type: Article

References (16)

1. P.C. Walsh Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate J Urol 163 2000 1802
2. S.D. Kundu, A.M. Cronin, F.J. Bianco How common is late recurrence after radical prostatectomy? J Urol 179 suppl. 2008 204 abstract 584
3. M.S. Cookson, A. Gunnar, A.L. Burnett Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes J Urol 177 2007 540
4. M. Schemper, T.L. Smith A note on quantifying follow-up in studies of failure time Cont Clin Trials 17 1996 343
5. A. Toledano, L. Chauveinc, T. Flam PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure; a study of 295 patients with a minimum 3-year follow up Brachytherapy 5 2006 122
6. Consensus statement: guidelines for PSA following radiation therapy American Society for Therapeutic Radiology and Oncology Consensus Panel Int J Radiat Oncol Biol Phys 37 1997 1035
7. M. Roach, G. Hanks, H. Thames Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendation of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965
8. M.B. Gretzer, B.J. Trock, M. Han A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria J Urol 168 2002 1419
9. M.E. Nielson, D.V. Makarov, E. Humphreys Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO Criterion-"Nadir + 2? Urology 72 2008 389
10. F.A. Critz A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition J Urol 167 2002 1310
11. F.A. Critz, A.K. Levinson, J.B. Benton Outcome after brachytherapy for prostate cancer with disease freedom defined by an undetectable PSA compared with nadir plus 2 J Urol 177 suppl. 2007 586 abstract 1765
12. C.R. Porter, K. Kodama, R.P. Gibbons 25-Year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series J Urol 176 2006 569
13. F.J. Bianco, P.T. Scardino, J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (" trifecta") Urology 66 2005 83
14. S. Loeb, Z. Feng, A. Ross Can we stop prostate specific antigen testing 10 years after radical prostatectomy? J Urol 186 2011 500
15. A. Billis, M.S. Guimaraes, L.L. Freitas The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies J Urol 180 2008 548
16. P.C. Albertson, J.A. Hanley, G.H. Barrows Prostate Cancer and the Will Rogers Phenomenon J Natl Cancer Inst 97 2005 17